Roivant Sciences

ROIV

Market cap $14B

Upgrade to unlock

Buy

Hold

Sell

8 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

Avg. target

$21

5% upside

High target

8 analyst ratings

positive

1 neutral

13%

negative

Analyst & Firm	Rating	Price Target	Upside Downside	Date
Citigroup Samantha Semenkow 67% 1-yr ROIV win rate				11 Nov ‘25 21 days ago
Goldman Sachs Corinne Jenkins 100% 1-yr ROIV win rate				18 Sep ‘25 2 months ago
Jefferies Dennis Ding 100% 1-yr ROIV win rate				18 Sep ‘25 2 months ago
JP Morgan Brian Cheng 100% 1-yr ROIV win rate				18 Sep ‘25 2 months ago
Guggenheim Yatin Suneja 100% 1-yr ROIV win rate				18 Sep ‘25 2 months ago
Leerink Partners David Risinger 100% 1-yr ROIV win rate				18 Sep ‘25 2 months ago
BofA Securities Chi Fong				18 Sep ‘25 2 months ago
HC Wainwright & Co Douglas Tsao 80% 1-yr ROIV win rate				18 Sep ‘25 2 months ago